Characteristics of SARS-CoV-2 Omicron BA.5 variants in Shanghai after ending the zero-COVID policy in December 2022: a clinical and genomic analysis

Characteristics of SARS-CoV-2 Omicron BA.5 variants in Shanghai after ending the zero-COVID policy in December 2022: a clinical and genomic analysis

IntroductionAn unprecedented surge of Omicron infections appeared nationwide in China in December 2022 after the adjustment of the COVID-19 response policy. Here, we report the clinical and genomic characteristics of SARS-CoV-2 infections among children in Shanghai during this outbreak.MethodsA tota...

Full description

Bibliographic Details
Main Authors:	Pengcheng Liu, Jiehao Cai, He Tian, Jingjing Li, Lijuan Lu, Menghua Xu, Xunhua Zhu, Xiaomin Fu, Xiangshi Wang, Huaqing Zhong, Ran Jia, Yanling Ge, Yanfeng Zhu, Mei Zeng, Jin Xu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-03-01
Series:	Frontiers in Microbiology
Subjects:	COVID-19 children genomics Omicron BA.5 variants SARS-CoV-2
Online Access:	https://www.frontiersin.org/articles/10.3389/fmicb.2024.1372078/full

Similar Items

Vaccine- and Breakthrough Infection-Elicited Pre-Omicron Immunity More Effectively Neutralizes Omicron BA.1, BA.2, BA.4 and BA.5 Than Pre-Omicron Infection Alone
by: Eveline Santos da Silva, et al.
Published: (2023-02-01)

Estimating relative generation times and reproduction numbers of Omicron BA.1 and BA.2 with respect to Delta variant in Denmark
by: Kimihito Ito, et al.
Published: (2022-06-01)

SARS-CoV-2 Omicron BA.4/BA.5 Mutations in Spike Leading to T Cell Escape in Recently Vaccinated Individuals
by: Maarten E. Emmelot, et al.
Published: (2022-12-01)

Classification of Omicron BA.1, BA.1.1, and BA.2 sublineages by TaqMan assay consistent with whole genome analysis data
by: Yosuke Hirotsu, et al.
Published: (2022-09-01)

Estimation of disease burden and clinical severity of COVID-19 caused by Omicron BA.2 in Shanghai, February-June 2022
by: Xinhua Chen, et al.
Published: (2022-12-01)

Clinical Manifestations of Infections with the Omicron Sub-Lineages BA.1, BA.2, and BA.5: A Retrospective Follow-Up Analysis of Public Health Data from Mecklenburg-Western Pomerania, Germany
by: Katja Verena Goller, et al.
Published: (2024-03-01)

First sequenced cases of Omicron BA.2 sublineage in Ecuador
by: D.A. Andrade-Molina, et al.
Published: (2023-09-01)

Characteristics and containment of the outbreak caused by the SARS-CoV-2 Omicron variants in Shanghai, China: A retrospective study
by: Hongrang Zhou, et al.
Published: (2022-01-01)

Vaccination effects on post-infection outcomes in the Omicron BA.2 outbreak in Shanghai
by: Qianhui Wu, et al.
Published: (2023-12-01)

Structural Insight into the Resistance of the SARS-CoV-2 Omicron BA.4 and BA.5 Variants to Cilgavimab
by: Shigeru Fujita, et al.
Published: (2022-11-01)

Introduction and Rapid Spread of SARS-CoV-2 Omicron Variant and Dynamics of BA.1 and BA.1.1 Sublineages, Finland, December 2021
by: Hanna Vauhkonen, et al.
Published: (2022-06-01)

Differences in Clinical Presentations of Omicron Infections with the Lineages BA.2 and BA.5 in Mecklenburg-Western Pomerania, Germany, between April and July 2022
by: Katja Verena Goller, et al.
Published: (2022-09-01)

Effectiveness and durability of mRNA-1273 BA.4/BA.5 bivalent vaccine (mRNA-1273.222) against SARS-CoV-2 BA.4/BA.5 and XBB sublineages
by: Bradley K. Ackerson, et al.
Published: (2024-12-01)

Limited neutralisation of the SARS-CoV-2 Omicron subvariants BA.1 and BA.2 by convalescent and vaccine serum and monoclonal antibodies
by: Alexander Wilhelm, et al.
Published: (2022-08-01)

Outcomes of laboratory-confirmed SARS-CoV-2 infection during resurgence driven by Omicron lineages BA.4 and BA.5 compared with previous waves in the Western Cape Province, South Africa
by: Mary-Ann Davies, et al.
Published: (2023-02-01)

The latest Omicron BA.4 and BA.5 lineages are frowning toward COVID‐19 preventive measures: A threat to global public health
by: Md. Rabiul Islam, et al.
Published: (2022-11-01)

Hot Climate and Humidity Do Not Interfere with BA.5 Omicron Spreading
by: Maria Grazia Cusi, et al.
Published: (2023-02-01)

The spike receptor-binding motif G496S substitution determines the replication fitness of SARS-CoV-2 Omicron sublineage
by: Ronghui Liang, et al.
Published: (2022-12-01)

The neutralizing response to SARS-CoV-2 Omicron variants BA.1 and BA.2 in COVID-19 patients and homologous and heterologous vaccinees
by: Francesca Dapporto, et al.
Published: (2022-11-01)

Spike mutations contributing to the altered entry preference of SARS-CoV-2 omicron BA.1 and BA.2
by: Bingjie Hu, et al.
Published: (2022-12-01)

SARS‐CoV‐2 Omicron (BA.4, BA.5) variant: Lessons learned from a new variant during the COVID‐19 pandemic
by: Gisou Erabi, et al.
Published: (2024-02-01)

Complex Mutation Pattern of Omicron BA.2: Evading Antibodies without Losing Receptor Interactions
by: Saathvik R. Kannan, et al.
Published: (2022-05-01)

The derived neutrophil to lymphocyte ratio can be the predictor of prognosis for COVID-19 Omicron BA.2 infected patients
by: Weiji Qiu, et al.
Published: (2022-11-01)

Effects of SARS-CoV-2 Omicron BA.1 Spike Mutations on T-Cell Epitopes in Mice
by: Yudong Wang, et al.
Published: (2023-03-01)

Early Detection of SARS-CoV-2 Omicron BA.4 and BA.5 in German Wastewater
by: Alexander Wilhelm, et al.
Published: (2022-08-01)

Characteristics and outcomes of COVID-19 patients during the BA.5 omicron wave in Tehran, Iran: a prospective observational study
by: Mohammadreza Salehi, et al.
Published: (2023-04-01)

The viral fitness and intrinsic pathogenicity of dominant SARS-CoV-2 Omicron sublineages BA.1, BA.2, and BA.5Research in context
by: Huiping Shuai, et al.
Published: (2023-09-01)

Omicron BA.2 Lineage, the “Stealth” Variant: Is It Truly a Silent Epidemic? A Literature Review
by: Giorgio Tiecco, et al.
Published: (2022-06-01)

Uninvited Guest: Arrival and Dissemination of Omicron Lineage SARS-CoV-2 in St. Petersburg, Russia
by: Anna Gladkikh, et al.
Published: (2022-08-01)

Mapping the Early Dispersal Patterns of SARS-CoV-2 Omicron BA.4 and BA.5 Subvariants in the Absence of Travel Restrictions and Testing at the Borders in Europe
by: Evangelia Georgia Kostaki, et al.
Published: (2022-12-01)

Low SARS-CoV-2 viral load among vaccinated individuals infected with Delta B.1.617.2 and Omicron BA.1.1.529 but not with Omicron BA.1.1 and BA.2 variants
by: Sivaprakasam T. Selvavinayagam, et al.
Published: (2022-09-01)

Comparing COVID-19 severity in patients hospitalized for community-associated Delta, BA.1 and BA.4/5 variant infection
by: Maja Sočan, et al.
Published: (2024-02-01)

SARS-CoV-2 Omicron BA.5: Evolving tropism and evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern
by: Anupriya Aggarwal, et al.
Published: (2022-10-01)

As the SARS-CoV-2 virus evolves, should Omicron subvariant BA.2 be subjected to quarantine, or should we learn to live with it?
by: Ren Xu, et al.
Published: (2022-11-01)

Tracking the first SARS-CoV-2 Omicron BA.5.1.3 outbreak in China
by: Xiaoxia Wang, et al.
Published: (2023-05-01)

Real world effectiveness of sotrovimab in preventing COVID-19–related hospitalisation or death in patients infected with Omicron BA.2
by: Alwaleed Behzad, et al.
Published: (2024-02-01)

Research of Epidemiologic Feature and Control of SARS-CoV-2 Omicron Subvariants BA.4 and BA.5
by: Yu WU, Jue LIU, Min LIU, Wannian LIANG
Published: (2022-10-01)

Viral load of SARS‐CoV‐2 Omicron BA.5 is lower than that of BA.2 despite the higher infectivity of BA.5
by: Yuna Takatsuki, et al.
Published: (2023-02-01)

Understanding spatiotemporal symptom onset risk of Omicron BA.1, BA.2 and hamster-related Delta AY.127
by: Chengzhuo Tong, et al.
Published: (2022-09-01)

Omicron subvariant BA.5 is highly contagious but containable: Successful experience from Macau
by: Cong Xu, et al.
Published: (2023-01-01)